Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome
Yves Allory(Institut Curie), Francisco X. Real(Universitat Pompeu Fabra), Marta Flández(Spanish National Cancer Research Centre), Cheno Abas(Erasmus MC), Irene Lurkin(Erasmus University Rotterdam), Manolis Kogevinas(Barcelona Institute for Global Health), Tahlita C.M. Zuiverloon(Erasmus MC), Josep Lloreta(Universitat Pompeu Fabra), Núria Malats(Spanish National Cancer Research Centre), Ellen C. Zwarthoff(Erasmus MC), Lars Dyrskjøt(Aarhus University Hospital), Mirari Márquez(Spanish National Cancer Research Centre), Alfredo Carrato(Hospital General Universitario de Elche), Ana Sagrera(Spanish National Cancer Research Centre), Kirstin A. van der Keur(Erasmus MC Cancer Institute), Miriam Marqués(Spanish National Cancer Research Centre), Willemien Beukers(Erasmus University Rotterdam), Ewout W. Steyerberg(Erasmus MC), José A. Lorente(Parc de Salut), Angela A.G. van Tilborg(Erasmus MC), Torben F. Ørntoft(Aarhus University Hospital), Enrique Carrillo de Santa Pau(Madrid Institute for Advanced Studies), Roy Masius(Erasmus MC), Marcel Vermeij(Erasmus MC)
Cited by 289
Related Papers
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.2k
Internal validation of predictive models
|Journal of Clinical Epidemiology|2001|2.6k
Towards better clinical prediction models: seven steps for development and an ABCD for validation
|European Heart Journal|2014|1.9k
Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research
|PLoS Medicine|2013|1.5k